CDKN1A and glioblastoma: Genetic disruption of SLFN11 stimulated expression of NFκB target genes, including CDKN1A (p21) and significantly delayed tumor growth and improved survival in a GBM orthotopic patient-derived xenograft (PDX) mouse model.